Abstract
In this issue of Cancer Cell, Hurst et al. report an integrated analysis of non-invasive (stage Ta) bladder cancer. Two genomic subtypes are distinguished by chromosome 9q loss, resulting in increased AKT/PI3K/mTOR signaling. Tumors from female patients have a higher frequency of KDM6A mutations. In this issue of Cancer Cell, Hurst et al. report an integrated analysis of non-invasive (stage Ta) bladder cancer. Two genomic subtypes are distinguished by chromosome 9q loss, resulting in increased AKT/PI3K/mTOR signaling and increased risk of recurrence. Tumors from female patients have a higher frequency of KDM6A mutations.
Original language | English (US) |
---|---|
Pages (from-to) | 550-551 |
Number of pages | 2 |
Journal | Cancer Cell |
Volume | 32 |
Issue number | 5 |
DOIs | |
State | Published - Nov 13 2017 |
ASJC Scopus subject areas
- Oncology
- Cell Biology
- Cancer Research